NCT01512810View on ClinicalTrials.gov

Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

August 26, 2021

Study Completion Date

August 26, 2021

Conditions
Endometrial Cancer
Interventions
PROCEDURE

Lymphadenectomy

Lymphadenectomy recommended, including: obturator, iliac (internal, external, common) and aortic lymph nodes

Trial Locations (1)

40536

University of Kentucky Markey Cancer Center, Lexington

All Listed Sponsors
lead

Frederick R. Ueland, M.D.

OTHER

NCT01512810 - Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer | Biotech Hunter | Biotech Hunter